It has been previously proved that NLRP3 inflammasome-mediated HMGB1 release plays a vital role in endothelial hyperpermeability during several metabolic disorders such as obesity, hyperglycemia, and diabetes [11, 25, 27]. Here, HMGB1 is linked to metabolic disease.